Geoffrey Del Rosario
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Computational Drug Discovery Methods, Melanoma and MAPK Pathways, Mathematical Biology Tumor Growth
Most-Cited Works
- → Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity(2019)185 cited
- → Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy(2021)161 cited
- → Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates(2016)128 cited
- → Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic–Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK Inhibitor(2012)79 cited
- → Modulating Antibody–Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification(2018)77 cited
- → Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody–Drug Conjugates with Self-Immolative Disulfide Linkers(2017)69 cited
- → An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia(2018)65 cited
- → Development of Efficient Chemistry to Generate Site-Specific Disulfide-Linked Protein– and Peptide–Payload Conjugates: Application to THIOMAB Antibody–Drug Conjugates(2017)59 cited
- → High-Resolution Accurate-Mass Mass Spectrometry Enabling In-Depth Characterization of in Vivo Biotransformations for Intact Antibody-Drug Conjugates(2017)53 cited
- → A homogeneous high-DAR antibody–drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides(2022)53 cited